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Abstract
Title: Performance on the Texas Functional Living Scale in a Memory Disorder
Clinic
Author: Kathryn Kim Grueninger, M.S.
Major Advisor: Anthony LoGalbo, Ph.D., ABPP
Objective: The present study examines the clinical utilization of an objective
performance-based measure in a memory disorder clinic sample.
Method: One year of archival cognitive testing data from a total of 176 Health
First Memory Disorder Clinic patients was utilized for the current study.
Participants were included in this study if they completed a brief
neuropsychological evaluation which included the Texas Functional Living Scale
(TFLS) and were also diagnosed with Normal Cognition (NC), Mild Cognitive
Impairment (MCI), or Alzheimer’s disease (AD). Patients’ psychosocial history
regarding their self-reported or informant-reported abilities with performing
instrumental activities of daily living (IADLs) was obtained from their electronic
medical records and included as predictors in this present study.
Results: Results showed that overall TFLS scores differed significantly across
diagnostic category. Specifically, scores from the AD group were significantly
lower than both MCI and NC groups. Correlation analysis revealed that overall
TFLS scores were positively and significantly correlated with overall MoCA total
score, suggesting that those who tend to score higher on the MoCA (a brief
screener of global cognitive functioning), also obtained higher TFLS score. Further
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correlational analyses demonstrated that there were positive correlations found
between TFLS scores and tests of executive functioning, as well as other tests of
cognition. Lastly, results demonstrated that patients who had reported impaired
abilities in at least 2 of 3 IADLs (i.e., medication management, financial
management, and driving) demonstrated lower TFLS scores, suggesting more
impaired abilities in completing basic adaptive functioning skills. Meanwhile, those
who reported intact abilities in 2 of 3 IADLs demonstrated higher TFLS scores,
suggesting more intact abilities in completing basic adaptive functioning skills.
Conclusion: Not surprisingly, the TFLS scores among the AD group were
significantly worse compared to MCI and NC groups; therefore, further assisting in
the differential diagnosis, particularly between individuals who fall between MCI
and AD presentations. Although TFLS scores positively correlated with measures
of global cognitive functioning (MoCA) and tests of executive functioning, they
also demonstrated positive correlations with many other areas of testing, suggesting
that the TFLS measures more than just executive functioning. Future research
studies should continue to repeat similar study designs to demonstrate reliability
strength, and to also increase sample size among the diagnostic categories. This
study was limited by the data collection time frame; in the future, it would be
helpful to have more time to collect data from more diverse diagnostic groups (i.e.,
including other dementias). However, this study suggests that the TFLS
demonstrated significant clinical utility, particularly with differential diagnosis
among the three diagnostic groups (with the exception of MCI and NC). This study
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also provides clinical relevance with making diagnostic decisions, which will then
assist with appropriate treatment recommendations.
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Chapter 1
Introduction
Current population trends continue to demonstrate the need for greater
understanding of the complexity in working with and providing care for individuals
who are 65 years and older. The United States Census Bureau (2017) projects that
the population in this age group will double over the next few years, rising from 49
million in 2016 to an estimated 95 million by 2060. With longer life expectancies,
individuals can continue to experience fulfilling lives with their family and friends
as well as maintain employment status or hobbies which contribute to their overall
well-being. While there may be more pleasurable and productive opportunities for
older adults who live longer, increased longevity also increases the chances of
certain factors which can be detrimental. For example, some may experience higher
medical costs due to increased likelihood of acquiring additional medical
complications, and higher cost of living, whether it is due to being placed in an
assisted living facility or acquiring in-home care. Additionally, older adults are at
increased risk of developing dementia given that advancing age is the greatest risk
factor for dementia.
A significant amount of research has focused on understanding the
numerous factors that contribute to maintaining or negatively affecting cognition as
we age. The study of cognitive decline has been an area of interest for years, dating
back to the early 1900s when Alois Alzheimer discovered a novel case of a 50 year
old woman who, upon autopsy, showed senile plaques and neurofibrillary tangles
in her brain, which later became some of the hallmark findings in the diagnosis of
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Alzheimer’s disease (Hippius, H., & Neundorfer, G., 2003). Since the discovery of
the brain anomalies found by Alzheimer, extensive time and research has been
undertaken to better identify, manage, and treat factors that are related to cognitive
decline among the elderly (Tuokko, H.A., Smart, C.M., 2018).
One of the significant advancements over the years involved adopting a
general consensus on how to accurately identify and further diagnose cognitive
decline, which is a significant component to effective detection and management of
the disease. In 1986, the National Institute on Aging (NIA) funded the Consortium
to Establish a Registry for Alzheimer’s Disease (CERAD) to help address the need
for standardized clinical procedures and neuropsychological assessments for
evaluating Alzheimer’s disease (Fillenbam et al., 2008). Through their research,
they were able to establish a standardized battery that was reliable and valid in
assessing Alzheimer’s disease. In addition to developing a brief, but adequate
battery of neuropsychological tests to assess AD, CERAD further introduced a
standardized means of viewing neuroimaging, as well as developing appropriate
training tools to be used within all of the Alzheimer Disease treatment centers
(Fillenbaum et al., 2008).
More recently, the American Psychiatric Association (2013) developed
specific criteria in the Diagnostic and Statistical Manual of Mental Disorders, fifth
edition (DSM-5) to distinguish a major versus mild cognitive decline. A mild
Neurocognitive Disorder (NCD) is diagnosed when the individual demonstrates
relatively minor declines in one or more cognitive domains. These domains
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include: (a) complex attention, (b) executive functioning, (c) learning and memory,
(d) language, (e) perceptual-motor, and (f) social cognition. These declines in
cognition must be evident either through objective neuropsychological testing or
via patient and/or collateral or clinician report, and these changes are a decline from
their previous premorbid functioning; however, maintaining intact instrumental
activities of daily living (IADL) functioning is a component of having a mild NCD
(APA, 2013). IADLs include complex behaviors, which often involve the ability to
live independently in the community, such as managing finances. Additionally, a
major NCD is diagnosed when either there is a significant decline in one or more
cognitive domains based upon standardized neuropsychological testing or the
patient or patient’s family or provider’s report is indicative of a significant decline
in comparison to their premorbid functioning (APA, 2013). These declines must be
significantly different from their expected baseline level of functioning, and the
changes must interfere with the individual’s ability to complete accurately their
instrumental activities of daily living (IADLs). Additionally, the suspected etiology
for cognitive decline can also be specified using various subtypes, including
Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, dementia due
to Parkinson’s disease, frontotemporal dementia (FTD), dementia due to a
traumatic brain injury, etc. (APA, 2013). The DSM-5 also allows for the provider
to specify whether the dementia is with or without a behavioral disturbance, which
includes behaviors related to exhibiting psychotic symptoms, mood disturbance,
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etc., as well as specifying the severity of the dementia (i.e., mild, moderate, or
severe; APA, 2013).
As part of a thorough memory evaluation, it is important to inquire about
the patient’s ability to perform their activities of daily living (ADLs). ADLs are
somewhat synonymous with the term adaptive functioning. Adaptive functioning
refers to daily skills that are needed for individuals to function independently, and
this can range from aspects of self-care such as bathing and maintaining personal
hygiene, to more general socialization and other independent living skills such as
driving and managing finances. It is of note that ADLs overlap with aspects of
adaptive functioning, particularly with respect to money management,
communication, driving, managing household tasks, etc. Whereas adaptive
functioning can be viewed as an overall umbrella term for daily living skills, ADLs
can further be differentiated into basic ADLs (BADLs), which typically pertain to
aspects of self-care such as bathing, dressing, and grooming, versus instrumental
ADLs (IADLs), which typically refer to more complex tasks such as managing
finances and medications, and driving. For the purpose of this paper, the terms
ADLs, IADLs and BADLs will be used to describe relevant aspects of an
individual’s independent living skills, although the main focus of study will be on
IADLs.
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Chapter 2
Study Purpose
The purpose of this study is to gather data on IADLs and
neuropsychological functioning from a memory disorder clinic population toward
examining the clinical utility of an instrument that measures IADLs: the Texas
Functioning Living Scale (TFLS). In order to understand the significance of the
study, an explanation of necessary background information pertaining to the
importance of accurate assessment of IADLs within a memory disorder clinic
population will be presented. Specifically, the introduction will include: (a) current
understanding of what we know about healthy aging; (b) a description of risk
factors related to development of cognitive impairment; (c) a description of Mild
Cognitive Impairment; (d) a description of Alzheimer’s disease and other related
dementias; (e) current use of measurements used to assess ADLs and their
limitations; a(f) background information about the TFLS; and (g) the specific aims
and hypotheses that will be addressed in this study.
Chapter 3
Review of the Literature
Healthy Aging
Various cognitive changes are typical, if not expected, throughout the aging
process. Better understanding and appreciation of typical cognitive changes allows
for more appropriate diagnostic conclusions, particularly when atypical cognitive
and behavioral presentations are observed, which then further assist with
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recommending subsequent treatment and interventions. Furthermore, understanding
which cognitive domains are impaired versus intact further aides the diagnostic
process and understanding of the trajectory of the diagnosis.
One aspect of cognitive functioning relates to an individual’s overall
general intellectual functioning. This domain differs from more specific cognitive
domains, such as memory, language, and attention, etc. Research has demonstrated
that elderly individuals tend to remain relatively intact with respect to their
crystalized abilities and knowledge, in comparison to fluid abilities and knowledge
(Craft, Cholerton, & Reger, 2017). In particular, crystallized intelligence describes
and includes an individual’s ability to remember knowledge and utilize that
knowledge for particular applications based on one’s experience and learned
behaviors; on the other hand, fluid knowledge considers an individual’s ability to
problem solve in novel situations (Kent, 2017). Additionally, individuals tend to
maintain much of their verbal abilities as they age, whereas visual abstract thinking
and aspects of executive functioning tend to slowly decline over time (Craft,
Cholerton, & Reger, 2017).
Many other cognitive domains can be impacted with the process of normal
aging as well. For example, different memory changes often occur. In particular,
the ability to learn new information, with a relatively slower learning curve over
repeated trials of learning the same information, becomes more difficult amongst
healthy aging adults (Luo & Craik, 2008; Craft, Cholerton, & Reger, 2017).
However, despite less information being encoded through learning, their retention
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of information appears relatively persevered (Craft, Cholerton, & Reger, 2017).
Furthermore, working memory, although also a component of the attention domain,
and episodic memory are also more negatively affected by normal age-related
changes (Luo & Craik, 2008). Prospective memory is another component of
memory that is important, especially for the aging population. In general,
prospective memory is an individual’s ability to intentionally remember to perform
a behavior at a later point in time (Luo & Craik, 2008). Zeintl et al. (2006) found
that prospective memory performance was able to predict subjective memory
complaints related to prospective memory within a sample of adults aged 65-80;
however, there was less significance when the individual was experiencing
depressive symptoms. Thus, they suggested that individuals who endorse a lower
level of emotional distress and memory concerns may be more likely to rely on
their self-reported prospective memory concerns, which can serve as a valid
measure of their prospective memory ability (Zeintl et al., 2006). Relying on our
prospective memory can be beneficial and useful in our daily living activities and
in determining the level of assistance, which may be necessary in one’s life,
particularly as it relates to their abilities to perform important IADLs
independently.
Individuals experiencing normal aging may also demonstrate difficulties
with completing aspects of executive functioning. Executive functioning can be
viewed as a general term, which includes cognitive flexibility, problem-solving,
planning, multitasking, and ability to cope with novelty (Lezak, Howieson, Bigler,
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& Tranel, 2012). They are an important cognitive ability, particularly when
performing “real world” behaviors as an adult. These skills allow adults to
complete complex actions, resulting in the ability to initiate goal-directed behavior,
sustain attention to tasks despite the interruption or distraction, but also the ability
to stop or disinhibit a behavior (McAlister & Schmitter-Edgecombe, 2016). As
individuals age, executive functioning tends to decline slightly, but there does not
appear to be significant changes in “real world” executive functions which would
involve multi-tasking or planning, in comparison to individuals who are presenting
with more severe dysexecutive problems (Craft, Cholerton, & Reger, 2017).
Aspects of language tend to change with age as well. Whereas basic
comprehension remains relatively preserved with aging, there are other aspects of
language where changes are relatively normal to observe (Craft, Cholerton, &
Reger, 2017). Confrontational naming tends to remain relatively intact with the
progression of aging, until a relative decline around the ages of 70 and older (Zec,
Markwell, Burkett, & Larsen, 2005). Coincidentally, word-finding difficulties tend
to be a common complaint with aging individuals, often referred to as the “tip of
the tongue” phenomena. However, these individuals tend to be able to recall the
correct word when given cues, suggesting that it is more of a retrieval problem than
the loss of abilities to name the object (Craft, Cholerton, & Reger, 2017).
Additionally, another language change that may be present with normal aging
involves verbal fluency. Verbal fluency is the rate at which an individual can
spontaneously recall words under a set amount of time, which fall under either a
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phonemic or semantic category. Although it can be viewed as an executive
functioning measure as well, due to the task requiring flexible thinking, selfregulation, and self-monitoring (Lezak et al., 2012), it also requires a language
retrieval component. While phonemic fluency tends to remain relatively stable as
age progresses, there tends to be more a decline in semantic or categorical fluency
(Clark et al., 2009).
In terms of attentional abilities, individuals experiencing normal aging may
not experience much change in sustained attention; however, there may be more
difficulties with complex, divided attentional tasks, such as during occasions when
multi-tasking is required (Craft, Cholerton, & Reger, 2017). Psychomotor
functioning tends to also decline with age. As individuals age, they tend to
demonstrate a slower processing speed but also slower motor skills, which is
consistent with normal age-related changes (Luo & Craik, 2008; Craft, Cholerton,
& Reger, 2017). Therefore, it is crucial to understand how expected slower
processing speed may affect other cognitive domains that are contingent on
accuracy and speed (Harada, Natelson Love, & Triebel, 2013). Lastly, visuospatial
skills may also see some degree of normal decline in performance as well, even
when speed is accounted for (de Bruin, Bryant, MacLean, & Gonzalez, 2016).
Understanding and recognizing typical changes in cognition that are
relatively normal for the elderly can be helpful particularly when interpreting
neuropsychological test data. Furthermore, considering an individual’s premorbid
functioning can be crucial to not only determine whether performance is normal
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when compared to a normative group, but also when compared to that individual’s
prior abilities. Baseline measures are often helpful for detecting cognitive changes;
however, the reality of all patient’s having baseline testing is rare. Furthermore, not
all assessments administer the same battery of tests, making it more difficult to
make direct comparisons. Therefore, understanding how to measure or estimate
premorbid intellectual functioning, without the comparison of baseline testing, can
be crucial and helpful in further delineating cognitive changes which would inform
subsequent treatment recommendations.
Premorbid functioning can often be estimated in different ways. One
method involves considering the individual’s demographics, such as education
level and occupational functioning, which are two variables, which have been
correlated with intellectual functioning (Schoenberg, Lange, Marsh, & Saklofske,
2011). An individual who obtained his or her bachelor’s degree may be expected to
perform at a higher level than someone who completed only nine years of formal
education. Test data from individuals who have obtained education levels at either
end of the spectrum should be interpreted differently because their level of
education may not fall within education levels of the sample used to develop the
neuropsychological testing norms, which could impact how their data is
interpreted. Similarly, an individual’s occupational attainment can also suggest the
level of cognitive ability that they have (Schoenberg et al., 2011).
Another way to measure an individual’s premorbid functioning is by
administering a standardized word-reading test. Studies have found that
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performance on a word-reading task is highly correlated with general intellectual
functioning (Nelson, 1982). One assumption and hence, advantage, of using these
tests is that verbal abilities, such as word reading, tends to be relatively intact
despite deteriorating cognition, therefore making it an effective means to assess
premorbid functioning (Bright, Kopelman, & Jaldow, 2002). Common standardized
word reading tests often utilized include the National Adult Reading Test (NART;
Nelson, 1982), North American Adult Reading Test (NAART; Uttl, 2002) and the
Advanced Clinical Scales Test of Premorbid Functioning (ACS TOPF).
Without taking into consideration an individual’s estimate premorbid level
of functioning, a potential limitation resulting in the misinterpretation of
neuropsychological data can lead to over-diagnosing as well as subsequent general
distress from the patient and their loved ones based on the inaccurate diagnosis.
Studies have indicated that it is not uncommon for normal aging individuals to
perform poorly on some aspects of testing, without actually having any cognitive
decline (Tuokko & Smart, 2018). Indeed, previous research has investigated how
normal aging adults may perform poorly on cognitive testing. For example,
Mistridis et al. (2015) conducted a study investigating the base rates of low
cognitive testing scores from the German version of the CERADNeuropsychological Assessment Battery (CERAD-NAB), which demonstrated that
60.6% of the normative sample obtained scores that fell at or below the 10th
percentile, further suggesting the need for better understanding how often it was
that normal aging adults were to obtain poor cognitive test scores. Therefore, the
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importance of additional clinical information such as social and medical history,
information regarding ADL performance, as well as brain imaging, can further aide
in differential diagnosis.
Risk Factors for Cognitive Decline
Multiple risk factors have been identified to be associated with cognitive
decline. Increasing age is the strongest risk factor for decline in cognition and
development of a neurodegenerative disease (Mielke, 2018; APA, 2013).
Cardiovascular risk factors, such as hypertension, diabetes, tobacco use, etc. have
also been found to be risk factors associated with cognitive decline (Craft,
Cholerton, & Reger, 2017; Peters et al., 2008). Genetic predisposition can also be a
risk factor. Specifically, individuals who carry the apolipoprotein E (ApoE) gene,
in particular the e4 allele, are at a higher risk of acquiring Alzheimer’s disease,
when compared to those who carry the e2 as well as the e3 allele (Liu, Kanekyo,
Xu, & Bu, 2013). In fact, carrying the e2 allele has actually been demonstrated to
be a protective factor against cognitive decline.
Mild Cognitive Impairment
Mild cognitive impairment (MCI) is often diagnosed when an individual
demonstrates relatively milder declines in cognition when compared to their prior
cognitive functioning, which are not severe enough to interfere with accurately
completing their IADLs (Lin et al., 2013). The diagnosis of MCI can be further
distinguished to indicate whether it is an amnestic or non-amnestic type. It is
referred to as an amnestic type when learning and memory is one of the impaired
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domains. Meanwhile, non-amnestic type refers to MCI when any other domain (not
including learning and memory) is impaired. Additionally, providers can also
specify whether the cognitive decline affects only a single cognitive domain or
multiple cognitive domains. Cognitive decline has often been viewed along a
spectrum, with MCI being seen as a decline in cognition in comparison from prior
functioning but also a precursor to developing dementia (Lin et al., 2013).
Assessment and accurate diagnosis of MCI represents crucial aspect of an
individual’s medical history due to its potential for predicting cognitive and
functional changes over time. Longitudinal studies demonstrated that
approximately 80% of individuals who were diagnosed with MCI were more likely
to develop Alzheimer’s disease within a span of 5 to 8 years (Craft, Cholerton, &
Reger, 2017). Research has demonstrated that an amnestic MCI is more likely to
convert to Alzheimer’s disease, whereas non-amnestic MCI may be more likely to
represent an early onset for other dementia etiologies, such as frontotemporal
dementia, vascular dementia, etc. (Craft, Cholerton, & Reger, 2017).
However, evidence also suggests that many people who are diagnosed with
MCI can either continue to have stable mild cognitive deficits over time, or revert
back to normal cognition, rather than progressively decline towards dementia
(Koepsell & Monsell, 2012). However, Koepsell & Monsell (2012)’s longitudinal
study further demonstrated that those individuals who reverted to normal cognition
were still at a risk of later cognitive decline, despite the initial reversion. Regardless
of subtype, the National Institute on Aging describes people with MCI as being
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able to still take care of themselves and complete typical daily activities but may
show signs of losing items, forgetting events or appointments, or having wordfinding difficulties in conversation, in comparison to same-aged peers (n.d.).
Nevertheless, a thorough and accurate evaluation of functional abilities is crucial to
the management of abilities and appropriate treatment that are associated with the
cognitive decline.
Alzheimer’s Disease and Other Related Dementia (ADRD)
The World Health Organization (WHO; 2019) defines dementia as a
progressive syndrome which causes various brain illnesses that affect one’s
cognition, especially in their learning and memory, as well as their everyday
activities. Age is the greatest risk factor for dementia; however, not everyone
develops dementia (Mielke, 2018; APA, 2013). In fact, according to the CDC
(n.d.), developing dementia is not a normal part of aging. Individuals with dementia
are generally characterized as having difficulties with impairments in their
instrumental activities of daily living (IADLs), with their basic activities of daily
living (BADLs) eventually being negatively impacted as the disease progresses
(Lin et al., 2013). As previously noted, activities of daily living (ADLs) can be
divided into two sub-categories: basic activities of daily living (BADL) and
instrumental activities of daily living (IADL). BADL are described as those
activities that involve personal care, such as bathing, dressing, etc. IADLs, on the
other hand, are daily activities that require more complex thinking and behaviors,
and include managing one’s medication, finances, etc. In the early stage of the
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disease, patients may have more difficulties remembering how to accurately
perform their IADLs without assistance; however, their ability to maintain their
hygiene and dress and bathe themselves may continue to remain intact. However,
with time and as more cognitive difficulties arise; even those BADLs may require
assistance from family members.
Alzheimer’s disease is a progressive neurodegenerative disease, and it is
the most widely diagnosed form of dementia, accounting for approximately 6080% of all dementia cases (alz.org). The estimated range varies likely depending on
the setting in which it is diagnosed, as well as the criteria used to make the
diagnosis. The severity of the disease can vary among individuals; however, it
generally causes worsening symptoms over time. The Alzheimer’s Association
reported that more than 5 million Americans who are 65 years and older are
diagnosed with Alzheimer’s disease, with women comprising 2/3 of this group
(alz.org; 2020). This gender difference may be more accounted by the fact that
women tend to have longer life longevity; therefore, women have a higher chance
of acquiring more cardiovascular problems and medical complications, further
increasing the chances of developing cognitive decline, when compared to their
male counterparts (Mielke, 2018). In fact, incidence studies in the United States
have reported that there were no significant gender differences in developing AD,
regardless of age (Edland et al., 2002).
There is currently no cure for Alzheimer’s disease. However, diseasemodifying treatments are available to prescribe for the treatment of cognitive
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decline. Two classes of drugs are often utilized within the aging population:
acetylcholinesterase inhibitors (AChEIs) and N-Methyl-D-aspartate (NMDA)
receptor antagonists, and while there can be benefits to their use, each come with
their own limitations as well.
AChEIs are often utilized due to their inhibitory reaction of cholinesterase,
an enzyme that increasingly breaks down acetylcholine (Tuokko & Smart, 2018).
AD is often associated with a decrease in the neurotransmitter, acetylcholine;
therefore, the inhibitory action of AChEIs prevents the decline in acetylcholine
(Birks, 2006). The most frequently used AChEIs prescribed include: donepezil
(Aricept), rivastigmine (Exelon), and galantamine (Razadyne) (Tuokko & Smart,
2018). A NMDA receptor antagonist, most common being memantine (Namenda)
is sometimes helpful, as its purpose tends to focus on blocking glutamatergic
activity, which can negatively affect memory (Tuokko & Smart, 2018). Namzaric
is another NMDA receptor antagonist, which combines both memantine and
donepezil.
When memory medications were compared to one another, memantine
demonstrated more efficacious results in the treatment of severe dementia cases
whereas AChEIs were often helpful in treating mild to moderate stages of dementia
(Di Santo, Prinelli, Adorni, Caltagirone, & Musicco, 2013). Understanding the
level of severity of cognitive impairment assists geriatricians and other medical
professionals with the treatment planning and potential use of disease-modifying
treatments, such as the above-mentioned drugs. Therefore, accurate assessment and
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subsequent diagnosis can help aide in making appropriate pharmacological
recommendations.
While certain medications offer advantages towards treating cognitive,
behavioral, and emotional disturbances within the aging population, they can also
potentially contribute to more problems if not carefully considered. For that
purpose, the American Geriatrics Society developed the Beers criteria to help
indicate specific medications that could become potentially harmful and
inappropriate for use with the elderly population. Medications become even more
problematic when taken incorrectly, which can become an issue with individuals
who have cognitive impairment, as they may forget to take their medications.
Inaccurate dosage of medications may further complicate or prevent the
improvement of cognition, behaviors, or emotions (Tuokko & Smart, 2018). Thus,
the evaluation of medication compliance and accurate self-management of
medications remains a significant detail in information gathering to again, not only
assist with differential diagnoses, but to also assist with developing appropriate
treatment recommendations (i.e., recommending supervision of medications).
Symptoms that are commonly associated with Alzheimer’s disease include
difficulties with acquiring newly learned information, disorientation, confusion, as
well as behavioral and mood changes, which may include suspiciousness of others,
wandering, difficulty speaking, swallowing or walking, as well as a lack of insight
into their cognitive deficits (alz.org). This disease not only impacts the individual
but also those who are involved in the patient’s care, such as the individual’s
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family. Individuals with AD often find themselves reverting in functioning,
requiring more and more assistance from others as the disease progresses. Knowing
the extent of the cognitive difficulties can help the family better prepare for
management of important financial and medical decisions, with the patient’s best
interest in mind. Whether changes involve just providing more oversight with the
completion of IALs or full management of them, the family can help protect their
loved one from making any poor decisions related to their finances or medical
management.
Activities of Daily Living Measures
Assessment of activities of daily living (ADLs) are a crucial component to a
memory evaluation, as it helps the provider differentiate whether the patient’s
deficits are considered to be MCI (mild NCD) or dementia (major NCD).
Oftentimes, ADLs are assessed using a variety of different self and collateral report
measures and questionnaires rather than formal or direct measurement. Although
these self-reported formats can be rich with information, there can also be
significant limitations with relying solely upon questionnaires. The subjective
nature of the questionnaire format allows individuals to either exaggerate or
minimize the difficulties that they may be experiencing when providing a selfreport, especially if the individual does not have insight into his or her cognitive
deficits. This can also be problematic for family/collateral reports because they may
be attempting to answer questions about their loved one’s functional behaviors
without full awareness of their abilities. For example, collateral information can be
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problematic, especially if loved ones do not live in the same home as the patient or
live out of state, Additionally, loved ones may not be intentionally observant of
their loved one performing IADLs accurately on their own.
As the need for assessing functional abilities using objective measures has
increased, test developers have introduced performance-based objective measures
for evaluating behaviors, which allows for less reliance on potentially inaccurate
self or collateral reports. These assessments generally require the patient to
demonstrate completion of common IADLs in a standardized format. Examples
include such tests as the Daily Living Test, which is part of the Neuropsychological
Assessment Battery (NAB; Stern & White, 2003) and the Independent Living
Scales (ILS; Loeb, 1996).
The NAB Daily Living composite score includes aspects of five different
cognitive subtests, each targeting common daily activities for people aged 18-97,
including a Driving Scenes test, Bill Payment test, Map Reading test, Judgment
test, and a memory component. Assessing judgment can be a crucial aspect of
evaluating functional abilities, particularly when it comes to making safe and
practical judgement decisions in their daily functioning, including but not limited to
their finances, medication, driving, and personal self-care. NAB’s Judgement test
asks the patient a series of questions related to hypothetical social and healthrelated reasoning (Ashendorf et al., 2018). Judgement is an aspect of an
individual’s executive functioning, with executive dysfunction being a common
syndrome of dementia (Craft, Cholerton, & Reger, 2017). Intact judgment suggests

19

that an individual can properly and safely self-manage and independently take care
of themselves and/or others. A lack of judgment can lead to poor decision-making,
which can cause more detrimental results or consequences for themselves or others
around them. The Judgment test is part of the overall Executive Functioning subtest
of the NAB. MacDougall & Mansbach (2013) investigated convergent validity
properties of the Judgment test within an assisted living facility, finding that the
overall Judgment score was significantly correlated with the oral version of the
Trail Making Test (TMT) B, as well as the MMSE scores, and the Lawton IADL
scale.
Memory is another component of the NAB and relevant to performing
ADLs, particularly with regard to an individual being able to perform the needed
activities without difficulties. Intact memory suggests that an individual can learn
and benefit from receiving repetitive information, with ability to retrieve stated
information over time. For aging individuals, remembering to take certain pills
during certain times of the day or even remembering how to accurately fill out
checks or address envelopes are important skills for adults.
Gavett et al. (2012) investigated the utility of each of the seven NAB
subtests in predicting accurate diagnoses, and they discovered that the Immediate
and Delayed Recall trials of the Daily Living Memory test demonstrated the best
predictive ability in identifying individuals with AD. They further demonstrated
that the NAB Driving Scenes, Bill Payment, and Judgment were also helpful in
being able to assist with ruling out a diagnosis of AD (Gavett et al., 2012). A
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limitation of the Judgment test is how heavily it relies on intact language capacity
and the inability to know if the individual would behave differently than what their
verbal responses indicate (MacDougall & Mansbach, 2013). Furthermore,
performance on the Bill Payment and Judgment tests were less sensitive in
predicting coinciding collateral-related concerns/lack of concerns in either of those
areas (Ashendorf et al., 2018).
The ILS test is also normed to assess IADLs for individuals who are 65
years and older, and it is composed of 5 subcategories, including
Memory/Orientation, Managing Money, Managing Home and Transportation,
Health and Safety, and Social Adjustment. A total of 140 points can be obtained,
with higher scores indicative of higher functional performance, and the entire test
takes approximately 45 minutes to administer (Loeb, 1996). Weiner et al. (2006)
compared ILS to the Test of Everyday Functional Abilities (TEFA), which
included all the TFLS subtests with an additional dressing component to measure
basic praxis abilities (Cullum et al, 2001). They ultimately removed the dressing
component due to 93% of their participants obtaining the maximum score (Weiner
et al., 2006). They found that the total TEFA score demonstrated a strong
correlation with the total ILS score, with each with each of the TEFA subscales
correlating with their respective corresponding subscales from the ILS (Weiner et
al., 2006). Limitations of the ILS test include the length of time it takes to
administer the entire test as well as being only normed to administer the test to
older adults (Gonzalez, Soble, Marceaux, & McCoy, 2017).
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Texas Functional Living Scale (TFLS)
The TFLS was developed to formally measure an individual’s functional
abilities by means of a performance-based objective approach that can be
administered quickly and easily (Cullum et al., 2001). The test was developed in
response to the need for more useful, performance-based tests to be available to
assess functional abilities within the dementia population (Cullum, Weiner, &
Saine, 2009). The original TFLS was composed of five subtests assessing basic
areas of functional abilities, with the combined total raw scores from each of the
subtests being easily converted to an overall TFLS T-Score (Mean=50, SD= 1.5),
reflecting an overall global score suggesting the degree to which an individual can
perform functional abilities. Total time to administer takes approximately 15-20
minutes.
The original version included the following subtests: (a) Time, (b) Money
and Calculation, (d) Communication, (e) Memory, and (f) Dressing, which
measures praxis abilities. The Dressing subtest was later removed; however, this
did not affect any of the results from the initial study (Cullum et al., 2001).
Therefore, the finalized TFLS version was comprised of only the four following
subtests: Time, Money and Calculation, Communication, and Memory. The Time
subtest asks the patient to perform common daily tasks including reading
information on a calendar as well as reading and set hands on a clock. The Money
and Calculation subtest asks the patient to perform basic calculations such as how
much time will pass from one time to another, and calculating monetary change
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involving simple subtractions. The Communication subtest asks the patient to
perform common tasks involving financial management such as filling out a check
for a fake water bill as well as completing a check to send in their payment to the
water company. The Communication subtest also includes common daily tasks
such as using a phonebook to look up a number and dial it on a phone, asking
patients to verbalize the steps involved in making a peanut butter and jelly
sandwich, and following basic instructions on a food label to demonstrate how they
would use and program a microwave. Lastly, the Memory subtest involves three
different activities, including one prospective memory task. At one point in the
middle of the test, the patient is directly told to remove three pieces of candy out of
a nearby bottle when a 5-minute alarm goes off. Their behavior is subsequently
scored based on whether they spontaneously remembered to remove the candy
without being prompted, after receiving a verbal prompt, after receiving a pointing
prompt, or if they were unable to recall what to do or removed the wrong amount of
candy. This prospective memory test is unique in that the patient is asked to
perform a planned activity at a future point in time. The last memory items involve
whether the patient can recall who they wrote the check to during the previous
check-writing task, and how much the check was written for.
The TFLS’s normative sample included 800 individuals, ranging from ages
16-90, making it a useful assessment that could administered to all adult ages. To
further validate the TFLS within the dementia population, Cullum et al. (2001)
conducted a study using a sample of 22 patients with possible or probable
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Alzheimer’s disease and 21 healthy controls (ages ranged from 64-85). They were
administered the Mini Mental Status Examination (MMSE) along with the TFLS,
while their caregivers completed the Blessed Dementia Rating Scale (BDRS)
(Cullum et al., 2001). The TFLS demonstrated good reliability, internal
consistency, and convergent and discriminant validity, and its easy administration
instructions and brief administration time make it a promising performance-based
measure to use within the dementia population (Cullum et al., 2001).
Other research studies have investigated the use of the TFLS with the use of
other commonly used neuropsychological tests. Nguyen, Copeland, Lowe,
Heyanka, and Linck (2019) focused on the impact that executive functioning
abilities could have on TFLS scores, and they found that Trail Making Test B (a
measure of set-shifting abilities) and the Similarities subtest from the Wechsler
Abbreviated Scale of Intelligence-II (WASI-II) test (a measure of abstract
reasoning) significantly predicted overall TFLS scores, whereas other executive
functioning measures, such as Controlled Oral Word Association Test (COWAT)
and WASI-II Matrix Reasoning subtest, did not. Based on their findings, they
concluded that set-shifting and abstract reasoning difficulties, which are aspects of
executive functioning, tend to have a greater influence on an individual’s
performance of IADLs (Nguyen et al., 2019).
Previous research has demonstrated that higher scores on the TFLS were
significantly correlated with MMSE scores, which is a commonly used dementia
screener in medical settings (Cullum et al., 2001). However, there has not been a
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study that has focused on the correlation between another common and slightly
more complex cognitive screener, the Montreal Cognitive Assessment (MoCA),
and performance on the TFLS.
Measuring functional abilities over time can be helpful in monitoring
disease progression, even in the context of receiving treatment. Saine et al. (2002)
investigated whether a cholinesterase inhibitor medication, Donepezil, which is a
commonly prescribed memory medication in the treatment of AD, influenced an
individual’s cognition (assessed using the MMSE) as well as their functional
abilities (assessed using the TFLS). A sample of 24 individuals who had AD were
treated with donepezil over a 12-month period; over the year, results demonstrated
that MMSE total score improvements paralleled TFLS score improvements by 3
months; however, by the end of the year, declines in both scores were noted (Saine
et al., 2002). The researchers concluded that the TFLS was sensitive to the
cognitive changes over a one-year period, noting that a decline in global cognitive
functioning can mirror a decline in overall functional abilities; therefore, the
performance one on one assessment can be informative of the other over time.
The advantage of utilizing an instrument like the TFLS in a clinical setting
is that it provides the clinician or treating physician with information related to
their patient’s functional abilities based on a performance-based objective measure,
without relying too heavily on self- report or collateral report, which may be flawed
or biased, as noted earlier. Another benefit of utilizing the TFLS specifically is that
it is a brief measure of functional abilities, which focuses on not only verbal
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responses but also the component of watching the patient demonstrate how to
perform activities, based on standardized administration and scoring. Many aspects
of the TFLS replicate common and essential activities that are frequently utilized
within an independent living setting. These activities are familiar to most
individuals, and they include reading and setting hands on a clock, reading
information from a calendar, and making basic monetary calculations using actual
coins and bills. Additionally, it measures a patient’s ability to remember to take
(hypothetical) medication out of a medication bottle after a specified period of
time, use commonly used home appliances such as a phone and microwave, and
demonstrate how to write a check and address an envelope. While the NAB
addresses some aspects of IADLs, and the ILS takes a relatively longer time to
complete the evaluation, the TFLS offers a more comprehensive measure of
functional abilities, which can be completed within a shorter period, making it
more appropriate to use within the elderly population.
Current Study
As noted earlier, when individuals develop dementia, they begin to lose
their abilities to accurately perform various functional activities of daily living. As
part of a standard cognitive evaluation, this information is typically only gathered
via questionnaires or by clinical interview, relying heavily on self-report. Critical
information regarding functional abilities is then used to make a differential
diagnosis, such as between MCI and dementia, and in determining important
clinical recommendations such as regarding treatment. This further illustrates the
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importance of assessing IADLs in a precise manner as a means toward making
accurate clinical diagnostic conclusions. Incorporation of an objective measure of
IADLs, such as the TFLS, can provide concrete evidence as to whether an
individual is capable of performing these functional abilities.
Chapter 4
Study Hypotheses
Hypothesis 1.
The overall TFLS score would differ among groups such that AD would
perform worse than MCI, and MCI would perform worse than WNL (which also
conveys that AD would be worse than WNL).
Hypothesis 2.
Higher overall TFLS scores (which would indicate more intact adaptive
functioning abilities) will be positively correlated with higher global cognitive
functioning, as measured by the Montreal Cognitive Assessment (MoCA) memory
screener.
Hypothesis 3.
TFLS scores will positively correlate with executive functioning tests (e.g.,
Trail Making Test Part B, Stroop Color Word Interference Test, and Modified
Wisconsin Card Sorting Test Executive Composite score).
Hypothesis 4.
Patients who report impairments in at least 2 of the 3 primary areas of
IADLs (medication management, driving, and managing finances) based on self
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and collateral report during the initial memory evaluation with their medical
provider, will tend to also demonstrate poorer TFLS scores when compared to
those patients who had no concerns or only reported impairment in one IADL area.
On the other hand, patients who reported intact IADLs in at least 2 of the 3 primary
areas will tend to demonstrate higher TFLS scores, suggesting more intact adaptive
functioning.
Chapter 5
Method and Procedures
Data Collection
This study utilized test data collected between 2019-2020 from the research
database at the Health First Memory Disorder Clinic in Melbourne, Florida.
Inclusion criteria included patients who completed one brief neuropsychological
evaluation with the TFLS as part of their battery and were given a diagnosis of
normal cognition, mild cognitive impairment, or Alzheimer’s disease (see
Procedures section below for more detail regarding diagnostic procedures).
In addition to obtaining demographic and neuropsychological test data, a
review of patients’ electronic medical records was also conducted as a means to
identify their performance of IADLs based on self- and/or collateral-report.
Specifically, three primary categories of IADLs were identified: medication
management, managing finances, and driving. Patients’ abilities in each of these
categories was coded according to their level of independence and accuracy in
performing them.
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Measures
All patients were administered a brief neuropsychological evaluation which
assessed various cognitive domains, including learning and memory, language,
attention and processing speed, executive functioning, visuospatial skills, and basic
adaptive functioning skills. The following tests were administered: (a) Shepherd
Verbal Learning Test (Norheim, N., Kissinger-Knox, A., Cheatham, M., Mulligan,
K., & Webbe, F., 2018), (b) Brief Visual Memory Test-Revised, (c) COWAT, (d)
Boston Naming Test, Short Form, (e) Western Aphasia Battery (WAB)
Comprehension and Repetition, (f) Boston Diagnostic Aphasia Examination
(BDAE) Cookie Theft Picture, (g) Trail Making Test A & B, (h) Stroop Color and
Word- Golden version, (i) Wechsler Adult Intelligence Scale-Fourth Edition
(WAIS-IV) Digit Span, (j) Modified Wisconsin Card Sorting Test (M-WCST), (k)
Clock Drawing Test, (l) Geriatric Depression Scale (GDS), (m) Geriatric Anxiety
Inventory (GAI), and the (n) Texas Functional Living Scale (TFLS). All tests were
attempted unless there were time constraints, or the tests were discontinued due to
patient confusion or frustration. See Table 1 for a breakdown of the
neuropsychological tests by cognitive domain.
Montreal Cognitive Assessment (MoCA)
The MoCA (Nasreddine et al., 2005) is a commonly used standardized
memory screener used to measure global cognitive functioning and to detect
cognitive impairment within the aging population by examining a range of
domains, such as visuospatial, executive functioning, language, attention, memory,
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abstract reasoning, and orientation. The total raw score that can be obtained is 30,
with education level being corrected for by adding 1 point for individuals who
completed less than 13 years of formal education. Higher scores are indicative of
more intact global cognitive functioning.
Texas Functional Living Scale (TFLS)
As an alternative to self-reported information regarding daily functioning,
the TFLS was developed as a performance-based adaptive measure of functional
abilities (Cullum et al., 2001). The TFLS consists of 21 items divided into four
separate domains or subscales: (a) Time, (b) Money and Calculation, (c)
Communication, and (d) Memory. The test generally takes about 15 to 20 minutes
to administer. Tasks include having the patient read and set the hands on a clock,
calculate basic monetary change, demonstrate how to write a check and fill out an
envelope, and remember to take “medication” out of a provisional medication
bottle after a predetermined set of time (prospective memory task). Once all items
are completed, a total raw score can be converted into a standardized T-score for
the overall TFLS score. The TFLS has demonstrated adequate reliability and
validity in several populations (Cullum et al., 2001; Gonzalez, Soble, Marceaux, &
McCoy, 2017), with the normative sample population age ranging from 16 to 90.
Procedures
Patients from a community memory disorder clinic underwent a formal
clinical interview with the geriatrician and licensed clinical social worker, who also
administered a brief, 10-minute cognitive screening instrument, the Montreal
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Cognitive Assessment (MoCA). If the physician recommended neuropsychological
testing to inform treatment, the patient was then referred and scheduled for a brief
neuropsychological evaluation. Testing was administered by a clinical psychology
doctoral student under the supervision of a board-certified licensed clinical
neuropsychologist. On the day of the evaluation, all patients signed a consent form
giving permission for their de-identified test data to be used for future research
purposes. Once the informed consent was obtained, participants underwent a short
battery of cognitive tests that assessed different areas of cognitive functioning, such
as language, memory and learning, executive functioning, attention and
concentration, processing speed, visuospatial skills, and basic adaptive functioning
skills. The total time of testing took approximately 2 hours. Testing was
administered in English (and those who identified as being Hispanic spoke and
comprehended English adequately enough for the purpose of the testing).
Upon completion of the evaluation, a multi-disciplinary case review
meeting was held, where the geriatrician, social worker, neuropsychologist,
neurologist, as well as pharmacy and clinical psychology doctoral students
collaborated and developed diagnostic impressions and recommendations based on
the data presented for each individual patient. Testing had to be temporarily
suspended from March to July 2020 due to unforeseen circumstances, and upon
resuming, a slightly modified test battery was implemented. As a result, some
patients did not receive the full battery of tests outlined above. Diagnostic
impressions were based on the overall presentation of evaluation data, including
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information obtained during the initial visit with the provider and social worker,
which included the psychosocial history, onset of memory loss, medical history,
along with the reported IADLs, review of neuropsychological test data, as well as
the review of available brain imaging.
Based on the above-mentioned information, the multidisciplinary team
diagnosed each patient using the Tenth Revision of the International Classification
of Diseases and Related Health Problems (ICD-10; WHO, 1992) diagnostic
criteria. Patients were considered to have cognition within normal limits based on
their overall neuropsychological testing presentation falling within normal ranges,
along with intact IADLs, and there was a consensus regarding the diagnosis by the
entire multidisciplinary team. Individuals who endorsed depression and/or anxiety
were also included in the group if their cognitive domains also fell within the
normal range. The MCI group included both amnestic and non-amnestic types, and
their final diagnosis was based on the Peterson (2004) criteria.
IADL Coding
In order to categorize the patient’s abilities in performing IADLs (i.e.,
medication management, financial management, and driving), patient and/or
collateral information was obtained from the patient’s electronic medical records
(EMR). The researcher initially coded the three IADLs as described above: 0 = not
impaired; able to perform task without any reported difficulty; 1 = patient currently
performs the activity but has been making errors; 2 = patient requires assistance or
oversight from their caregiver; or 4 = unknown, meaning that the information
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obtained varied between provider notes found in the EMR or the information was
unavailable. As an example of discrepancies noted in the EMR, the medical
provider’s notes may not have noted any difficulties with managing their
medications, while the social worker’s notes may have indicated that the patient
was missing doses and needed reminders from family. These discrepancies made it
difficult, at times, to determine which information was most accurate related to the
patient’s abilities.
Using the categorization system described above, a total of 3 of the 176
patients used in this study had one IADL coded as a “4.” For 2 of these patients,
discrepant information was found initially in their EMR where one note did not
report any problems with the specific IADL, but then another area noted that the
patient required assistance/was dependent for that IADL; therefore, the researcher
subsequently changed both of these “4’s” to “2’s,” suggesting that these patients
needed assistance or were dependent on others to complete their IADL. For the 3rd
patient, updated IADL information was not available at the time of the initial
evaluation, which prompted the initial coding of a “4.” It was not until shortly after
the initial evaluation date that another office visit was made, and the EMR provided
updated information, at which point the researcher was able to then code the
activity as a “2,” due to the patient’s records indicating that their family was needed
to assist with completing all IADLs. Therefore, all 3 of these cases that were
initially coded as a “4” were ultimately changed to a “2,” indicating impaired
IADLs based on their EMR.
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Subsequently, in order to classify whether the patient demonstrated
generally “intact” versus “impaired” IADLs overall, the researcher then proceeded
to code IADLs in the following manner: “1” = “Intact,” meaning that the patient
had a code of “0” on 2 or all 3 of the IADLs as outlined above; “1” = “Impaired,”
meaning that the patient had a code of “1” or “2” on 2 or all of the IADLs as
outlined above. Using this coding method, a total of 107 patients were concluded to
demonstrate “impaired” overall IADLs, while 69 patients were concluded to have
“intact” IADLs. One patient had to be removed from the “impaired” group due to
discontinuing early on the TFLS; therefore, a TFLS total score could not be
obtained for that individual. Applying diagnostic categories to this classification
thus resulted in a total of 15 AD, 32 MCI, and 22 NC patients in the “Intact” group,
and a total of 71 AD (1 removed due to not completing the TFLS), 30 MCI, and 5
NC patients in the “Impaired” group.
Research Design and Analysis of Data
Permission was granted to the researcher by the Health First Memory
Disorder Clinic to utilize their research database. Prior to analyzing data, approval
from the Florida Institute of Technology Institutional Review Board (IRB) was
obtained by the researcher. Informed consent was obtained prior to each participant
completing their neuropsychological evaluation. The study utilized a crosssectional design.
Descriptive statistics were obtained to include means, standard deviations,
and frequencies for patient demographic variables. Analysis of variance (ANOVA)
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was used to examine the relationship between multiple variables. Correlational
analyses were conducted to determine the relationship between two conditions. An
independent samples t-test was conducted to examine group differences between
those who reported “intact” versus “impaired” IADLs. Data were analyzed using
the Statistical Package for the Social Sciences (SPSS)-Version 25.
Chapter 6
Results
Participants
An overall total of 254 patients were tested between 2019-2020. Out of
these patients, 78 did not meet the diagnostic criteria for inclusion in this study
(i.e., they were diagnosed with other conditions, such as Mixed Dementia,
Dementia Unspecified, Unspecified Neurocognitive Disorder, Depression, Anxiety,
etc.). After removing individuals who did not meet the diagnostic criteria for
inclusion, a total of 176 patients were included in the current study. Among them,
87 patients were diagnosed with Alzheimer’s disease (AD; 62.1% female, M =
80.71, SD = 6.62), 62 patients were diagnosed with Mild Cognitive Impairment
(MCI; 59.7% female, M = 80.76, SD = 5.88), and 27 patients were diagnosed with
Normal Cognition (NC; 48.1% female, M = 78.48, SD = 6.00). The average
education level was 13.38 (SD =2.50) for the AD group, 13.94 (SD = 2.70) for the
MCI group, and 14.70 (SD = 2.76) for the NC group. Among the 176 patients, a
majority of them self-identified as being Caucasian/White (92.0%), with the
remaining patients self-identifying as African American/Black (4.0%), Asian
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(1.1%), Native American (0.6%), or No Response (2.3%). Only 5.1% identified as
having Hispanic ethnicity. See Table 2 for further patient demographic information.
Statistical Analyses
Age and Education. There was not a significant effect of age among the
three diagnostic groups [F(2, 173) = 1.470, p = .233]. Similarly, there was not a
significant effect of education among the three diagnostic groups [F(2, 173) =
2.823, p = .062].
TFLS and Differentiating Diagnoses. This study explored whether TFLS
scores differed among diagnostic groups such that individuals who were
cognitively intact or only demonstrated mild cognitive impairments, such as those
with MCI and NC, might perform better than individuals with a more severe
cognitive impairment, such as those with AD. A one-way ANOVA was conducted
to determine whether there was a significant difference in TFLS scores among
diagnostic groups. The assumption of homogeneity of variances was not met
(Levene’s statistic = 12.533, p = .000). Therefore, a Kruskal-Wallis H test was
conducted to examine the differences on TFLS scores according to the diagnostic
group (χ2 (2) = 90.64, p < .001). Results showed that there was a statistically
significant difference in TFLS scores among the different diagnostic groups (see
Figure 1). In particular, the TFLS t-scores among the AD group (M = 31.70, SD =
5.25) were significantly lower compared to the t-scores from the MCI (M = 42.77,
SD = 8.01) and NC (M = 48.67, SD = 8.61) group, which partially supports the first
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hypothesis. However, there was not a significant difference between the MCI and
NC group.
TFLS and Global Functioning. A bivariate correlational analysis was
conducted to determine if higher TFLS T-score was positively correlated with
higher global functioning (i.e., using the MoCA total score). Results showed that
there was a positive and strong correlation between overall MoCA total score and
TFLS score, suggesting that having more intact global cognitive functioning is
related to having more intact functional abilities (r = .702, p < .001). These results
support the second hypothesis that higher overall TFLS T-scores would be
positively correlated with higher global cognitive functioning.
TFLS and Executive Functioning. A bivariate correlational analysis was
conducted to determine if overall TFLS score was positively correlated with
various tests of executive functioning. In support of the third hypothesis, results
showed that TFLS scores were positively and moderately to strongly correlated
with multiple measures of executive functioning, including the Clock Drawing Test
(r = .528, p <.001), M-WCST Executive Function Standard Score (r = .501, p <
.001), M-WCST number of perseverative errors ( r = .487, p <.001), Stroop Color
Word (Golden version; r = .483, p < .001), and Trail Making Test Part B (r = .368,
p < .001).
Similarly, other measures of attention and processing speed were positively
and moderately to strongly correlated with TFLS scores as well, including the
WAIS-IV Digit Span subtest (r = .541, p < .001), Trail Making Test Part A (r =
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.427, p < .001), Stroop Color Naming (r = .384, p < .001), and Stroop Word
Reading (r = .322, p < .001). While these measures are considered tests of attention
and processing speed, they also are somewhat related to the construct of executive
functioning as the Stroop tasks of word reading and color naming and Trail Making
Test Part A are subcomponents to other previously mentioned executive
functioning tests. Therefore, it is not totally unexpected for these tasks to
demonstrate a positive correlation with the TFLS. In fact, these results further
support the hypothesis that the overall TFLS T-score is positively correlated with
measures of executive functioning, as well as other cognitive tests that may have
executive functioning characteristics embedded within the test.
Further correlations were conducted to assess the relationship between
TFLS scores and other measures of cognition. Coincidentally, results also
demonstrated that there was a positive and moderate to strong correlation between
TFLS scores and language tests, including MackSF4 (r = .505, p < .001), semantic
fluency (r = .509, p < .001), phonemic fluency (r = .365, p <.001), and subtests
from the Western Aphasia Battery including Repetition (r = .376, p < .001) and
Comprehension (r = .304, p <. 001). Additionally, results demonstrated that there
was a positive and moderate correlation between TFLS scores and delayed recall
from memory tasks, including the Supraspan Word List Percent Retained (r = .494,
p < .001) and BVMT-R Percent Retained (r = .304, p < .001).
Lastly, results demonstrated that there was a negative correlation between
TFLS scores and mood questionnaires, GAI (r = -.253, p < .05) and GDS (r = -
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.170, p <.05). Although significant, these correlations were noted to be relatively
weaker when compared to measures of executive functioning.
TFLS and Reported IADLs A Mann Whitney test indicated that TFLS
scores in the “Intact” group (M = 43.30, SD = 10.23) were statistically significantly
higher than for the “Impaired” group (M = 34.94, SD = 7.58), U = 1823.50, p <
.001. This supports the fourth hypothesis that patients who reported generally more
impaired IADLs tended to obtain lower scores on the TFLS score, suggesting more
difficulties with performing adaptive functioning. On the other hand, those patients
who reported fewer difficulties, or none at all, in their IADLs tended to obtain
higher TFLS scores, suggesting more intact abilities with performing adaptive
functioning (see Figure 2 below).
Chapter 7
Discussion
Impact of Study
As previously suggested, being able to accurately diagnose memory
disorder clinic patients is imperative, particularly for the subsequent treatment
recommendations following the evaluation. This can be even more important for
those individuals who tend to fall on the borderline between an MCI and AD
diagnosis. As noted earlier, a significant factor that determines whether a patient
has progressed to dementia is determining whether they have intact IADLs.
Obtaining that information is often collected via clinical interviews or
questionnaires. For this study, information regarding IADLs was obtained from the
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patient and family or caregiver during the patient’s office visit with the geriatrician
or medical provider as well as with the social worker.
Current results revealed significant differences in TFLS total score among
diagnostic groups, in that individuals with AD performed worse than those with
MCI and those with normal cognition. This supports the first hypothesis and
suggests that the TFLS has clinical utility in making a differential diagnosis among
these diagnostic categories. In particular, it may assist with the challenging
differential between MCI and AD, whereas individuals with MCI performed
relatively similar to the NC group with components of the TFLS. Future research
should aim to develop a better understanding of which components of the TFLS
tend to be more difficult for individuals with MCI, and whether these difficulties
might be early signs of progressive decline toward dementia.
TFLS scores were also positively correlated with MoCA total scores,
supporting the second hypothesis and suggesting that those who score high on the
MoCA tended to also perform relatively well on the TFLS. Meanwhile, as greater
impairment is noted in patients’ global cognition using a brief memory screener
such as the MoCA, medical providers should become more conscientious of
obtaining accurate information regarding their IADLs. Future research should aim
to explore TFLS scores and MoCA scores over time as a means to better
understand the reliability and consistency of scores between the two tests at
different stages of disease progression.
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The TFLS demonstrated moderate to strong positive correlations with other
tests of executive functioning, supporting the third hypothesis; however, the TFLS
demonstrated positive correlations with tests in other cognitive domains as well,
including memory, language, and attention and processing speed. While this does
not support the notion that the TFLS is exclusively an executive functioning task,
correlations with measures across multiple cognitive domains is not completely
unexpected, as there are components of the TFLS that clearly involve other
cognitive functions. For example, there is a memory (delayed recall) subsection
within the TFLS, as well as tasks requiring language such as comprehension and
writing. Future research might therefore consider exploring relationships among
neuropsychological tests in these cognitive domains and specific subscales of the
TFLS.
Lastly, individuals with “Impaired” IADLs based on EMR records were
found to perform more poorly on the TFLS compared to individuals with “Intact”
IADLs, supporting the fourth hypothesis. This provides some degree of ecological
validity to the TFLS in terms of corresponding to reported difficulties in aspects of
daily functioning including driving and managing finances and medications. These
results seem to further solidify the use of the TFLS as part of a neuropsychological
battery to assist in determining patients’ abilities in performing IADLs.
Limitations and Areas for Future Research
A significant limitation of this study was the small sample size per
diagnostic group, in part due to the limited one-year time frame during which test

41

data were collected. Future research should consider incorporating larger sample
sizes within diagnostic groups toward extending these results.
Relatedly, this study was limited to focusing on only three diagnostic
groups (i.e., NC, MCI, and AD). Although AD may be the most prominent type of
dementia that is diagnosed, difficulties with adaptive function and IADLs are not
exclusive to AD and in fact many other types of dementias are observed in a
memory disorder clinic setting. The lack of diagnostic variability included in this
study prevents the ability for these results to be completely generalizable to the
overall memory disorder population. It should also be noted that a majority of
patients included in this study were Caucasian, limiting the ability to generalize to
communities where more diverse populations exist.
Another limitation of this study involves difficulties obtaining accurate
descriptions of patients’ functional abilities (IADLs) in their electronic medical
records. This information was obtained from the medical provider and social
worker notes; however, as noted above, there were times when a discrepancy
existed between these two sets of provider notes. Being uncertain about which
EMR note was more accurate, resulting in the researcher having to make a decision
that tended to lean toward the more impaired result, was a limitation of this study
as well. Unfortunately, the researcher could have erred on the wrong side;
therefore, the patient could have been coded incorrectly and then labeled as
“impaired” versus “intact” in performing IADLs.
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In order to help make the results more generalizable, a future area of study
would be to replicate or conduct similar studies with a larger sample of individuals
(with a wider range of memory disorders). It would also be beneficial to obtain
more data from a more culturally and ethnically diverse group of individuals. In
doing so, it will help further demonstrate more generalizability to the overall
population as well as to other communities that may not be significantly Caucasian.
For this study, three main IADLs (i.e., managing finances and medication
and driving) were primarily assessed for each patient via self and informant report.
This posed another limitation of the study in that the TFLS does not include any
specific section assessing driving abilities. Although there are components of the
TFLS that assess for aspects of money management and medication management, it
lacks the assessment of an individual’s driving abilities. Although the incorporation
of the Trail Making Test Part B may be a suitable and appropriate measure to
assess safe driving in the elderly population (Papandonatos, Ott, Davis, Barco &
Carr, 2015), future studies may want a more face valid performance-based measure
that assess driving skills. For instance, the utilization of the Driving Scenes test of
the Neuropsychological Assessment Battery (NAB; Stern & White, 2003) may be a
useful additional measure to incorporate in a neuropsychological battery when there
are concerns regarding an individual’s abilities to perform their IADLs, such as
driving, accurately.
Future research should continue to look at the subtests of the TFLS (not
just the overall TFLS T-score) and assess whether there are correlations among the
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subtests and other neuropsychological tests to help differentiate which cognitive
domains may be more relevant within each subtest.
Lastly, it should be noted that data collection occurred between March 2019
and October 2020. Although there were four months that TFLS data were not
collected due to COVID-19 related restrictions and safety concerns, a total of 28
patients were eventually included following the re-opening of the clinic and with
safety measures in place with administering the TFLS. Although it is unclear
whether there are extraneous factors that could result in confounding factors related
to the testing prior and after COVID-19, it should be considered and investigated in
the future to determine the extent of COVID-19 emotional and medical factors in
the aging population.
Conclusion
The TFLS has introduced a new possibility for more accurate assessment of
adaptive functioning to aid diagnosis within a memory disorder clinic population.
This is particularly helpful given the subsequent treatment recommendations that
are provided, for both the patient and the family. Although Cullum et al. (2001)
introduced and normed this test for people 16-90, it is even more imperative within
the elderly population where a change or decline in functional status can occur with
age. The utilization of the TFLS in a memory disorder clinic provides objective
data to the provider which assesses adaptive functioning, removing potential
inaccuracies or discrepancies in self and collateral reports. This can be even more
helpful in cases when the patient lives alone and there is no one to verify that
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he/she is performing their IADLs accurately and without difficulty. As the aging
population continues to live longer, and medical visits regarding memory concerns
become more frequent, having an objective measure to assist with the overall
assessment and diagnosis can be extremely helpful within the medical profession to
counteract any patient situations where obtaining accurate information may not be
feasible.
Additionally, observations regarding TFLS performance among diagnostic
groups within a memory disorder clinic population, and the relationship between
performances on the TFLS and other neuropsychological tests, benefits providers
within the neuropsychology field by improving confidence in the ability to
ascertain the degree to which a patient might be experiencing difficulties in aspects
of daily functioning. This clinical information can then be utilized to improve
diagnostic accuracy, particularly in differentiating individuals with MCI from early
stages of AD.
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Table 1.
Neuropsychological Measures by Cognitive Domain
Learning/
Memory

Language

Supraspan
Word List
(verbal
memory)
BVMT-R
(visual
memory)

Controlled Oral
Word
Association Test
MackSF4

WAB
Comprehension/
Repetition

Attention/
Processing
Speed
Trails A

Executive
Functioning

Visuospatial

IADLs

Global
functioning

Trails B

Clock
Drawing Test

TFLS

MocA

Stroop
Word
Reading
and Color
Naming
WAIS-IV
Digit Span

Stroop
Color-Word

M-WCST
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Table 2.
Descriptive Statistics of Patient Demographic Information
Variable
AD group
Gender
Female
Male
Race and Ethnicity
American Indian
Asian
Black
White
No Response
Hispanic
Age
60-69
70-79
80-89
90+
Educational Attainment
0 through 11th grade
High School graduate
Some college or associate degree
College graduate or more
MCI group
Gender
Female
Male
Race and Ethnicity
American Indian
Asian
Black
White
No Response
Hispanic
Age
60-69
70-79
80-89
90+
Educational Attainment
0 through 11th grade
High School graduate
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N

Percent

54
33

62.1
37.9

1
2
6
75
3
7

1.1
2.3
6.9
86.2
3.4
8.0

5
33
44
5

5.7
37.9
50.6
5.7

12
33
16
26

13.8
37.9
18.4
29.9

37
25

59.7
40.3

0
0
1
61
0
0

0
0
1.6
98.4
0
0

2
23
33
4

3.2
37.1
53.2
6.5

5
23

8.1
37.1

Some college or associate degree
College graduate or more

13
21

21.0
33.9

13
14

48.1
51.9

0
0
0
26
1
2

0
0
0
96.3
3.7
7.4

2
14
10
1

7.4
51.9
37.0
3.7

1
9
4
13

3.7
33.3
14.8
48.1

NC group
Gender
Female
Male
Race and Ethnicity
American Indian
Asian
Black
White
No Response
Hispanic
Age
60-69
70-79
80-89
90+
Educational Attainment
0 through 11th grade
High School graduate
Some college or associate degree
College graduate or more

56

Table 3. Means, standard deviations, and correlations with neuropsychological
tests
Variable

M

SD

r

19.52

4.79

.702**

Stroop Color Word

8.03

3.81

.483**

Stroop Interference

49.30

9.32

.254**

Trail Making Test Part B

8.29

3.51

.368**

M-WCST Executive Function

86.01

18.15

.501**

M-WCST Perseverative Errors
Clock Drawing Test
Attention and Processing Speed

43.81
8.23

11.05
2.05

.487**
.528**

WAIS-IV Digit Span
Stroop Word Reading
Stroop Color Naming
Trail Making Test Part A
Language

8.27
8.60
8.82
8.65

3.15
2.89
3.20
3.80

.541**
.322**
.384**
.427**

9.34
6.98
11.70
11.33
6.52

2.99
2.98
3.01
1.14
0.94

.365**
.509**
.505**
.304**
.376**

65.64
37.55

53.67
33.63

.304**
.494**

3.74
6.48

4.78
5.22

-.253**
-.170*

MoCA
Executive Functioning

Phonemic Fluency
Semantic Fluency
MackSF4
WAB Comprehension
WAB Repetition
Memory
BVMT-R Percent Retained
Supraspan Percent Retained
Mood
GAI
GDS
Note. * p < .05, **p<.01
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Figure 1. Comparison of TFLS scores by Diagnosis
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Note. **p<.001

58

Alzheimer's disease

Figure 2. Comparison of Average TFLS scores Between Impaired/Intact Groups
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